BICYCLE THERAPEUTICS PLC — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Bicycle Therapeutics Inc. entered into a consulting agreement with Janice Bourque effective June 17, 2026, for two years (auto-renewable for one year). Bourque will provide strategic advice in her areas of expertise at an annual fee of GBP 12,000 (~$15,000 USD equivalent), payable monthly in arrears. She is classified as an independent contractor with standard IP assignment, NDA, and non-compete provisions; she may also receive equity grants under the company's 2020 Equity Incentive Plan.
Why this rating
Routine consultant engagement at minimal cost relative to $266.7M market cap; negligible financial or operational impact.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.